This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to learn whether an investigational medication (not FDA approved for osteoporosis) called Zoledronic Acid is safe and will treat osteoporosis by reducing bone loss and fractures in postmenopausal women. This is an investigator initiated trial.
Showing the most recent 10 out of 721 publications